Open AccessCD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximab
Author(s) -
R. Arriga,
S. Caratelli,
G. Lanzilli,
A. Ottaviani,
C. Cenciarelli,
T. Sconocchia,
G.C. Spagnoli,
G. Iezzi,
M. Roselli,
D. Lauro,
A. Coppola,
G. Dotti,
S. Ferrone,
G. Sconocchia
Publication year - 2020
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/6n83-yp54
Subject(s) - cetuximab , kras , cancer research , colorectal cancer , cd16 , medicine , chemistry , oncology , immunology , cancer , immune system , cd3 , cd8